English
Press Release
15 April 2024
The new "Skyline" clinical trial, which has just opened as part of the RHU CASSIOPEIA Future Investment Program at Institut Curie, the 1st European center for breast cancer management, has a double objective: to evaluate the effectiveness of a new combination of two immunotherapies in combination with chemotherapy in women with triple-negative breast cancer and to better visualize the cancer and its possible metastases thanks to innovative imaging used for the first time in France.
All
Medical
Scientific
Innovation
Generosity
Institutional
Event
Public health
No post
Get all multimedia resources (videos, podcasts, images, infographics) for our latest medical, scientific, institutional and event news here.
know more about the Institut Curie and our key figures, our activities...
For further information, please contact the press office